Respiratory and allergic outcomes among 5-year-old children exposed to pesticides

Jessica Y Islam1,2, Jane Hoppin1,2, Ana M Mora3,4

  • 1Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA.

Thorax
|February 25, 2022
PubMed

Insights

Current exposure to pyrethroids and mancozeb pesticides may negatively impact children's respiratory and allergic health. Pyrethroid exposure is linked to wheezing and asthma, while mancozeb may contribute to lower respiratory tract infections in children.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Limited understanding of pesticide impacts on children's respiratory and allergic health.
  • Study focuses on prenatal and current pesticide exposures in a Costa Rican cohort.
  • Investigates associations with specific respiratory and allergic outcomes in children.

Purpose of the Study:

  • To evaluate the associations between prenatal and current pesticide exposures and respiratory/allergic outcomes in children.
  • To identify specific pesticides linked to adverse health effects in early childhood.
  • To inform public health strategies regarding pesticide use and child health.

Main Methods:

  • Assessed urinary metabolite concentrations of various pesticides (insecticides, fungicides, 2,4-D) in 303 5-year-old children.
  • Collected caregiver-reported data on respiratory (asthma, LRTI, wheeze, cough) and allergic (nasal allergies, itchy rash, eczema) outcomes.
  • Utilized multivariable logistic regression to model associations between high pesticide metabolite concentrations and health outcomes.

Main Results:

  • High current pyrethroid exposure associated with increased odds of wheeze, itchy rash, doctor-diagnosed asthma, and lower respiratory tract infections (LRTI).
  • High current ethylene thiourea (ETU), a metabolite of mancozeb, showed a potential association with LRTI.
  • Associations were consistent when pesticide metabolites were modeled as continuous variables; other pesticide exposures showed null or inconsistent results.

Conclusions:

  • Current pyrethroid exposure may adversely affect children's respiratory and allergic health at age five.
  • Current mancozeb exposure might be a contributing factor to LRTI in children.
  • Findings highlight the importance of considering widespread pesticide use in homes and agriculture, such as pyrethroids and mancozeb, in relation to child health.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.1K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
524
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
681
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K